Global Anticoagulants Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Anticoagulants Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

According to APO Research, The global Anticoagulants market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Anticoagulants include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants.
The Anticoagulants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson.
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company
Anticoagulants segment by Type

Platelet Aggregation Inhibitors (PAI)
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Direct Factor Xa Inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Anticoagulants segment by Application

VTE
ACS/MI
AF
Others
Anticoagulants Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Anticoagulants companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Anticoagulants Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Anticoagulants Market Size by Region (2019-2030)
1.4.1 Global Anticoagulants Market Size by Region (2019-2024)
1.4.2 Global Anticoagulants Market Size by Region (2025-2030)
1.5 Key Regions Anticoagulants Market Size (2019-2030)
1.5.1 North America Anticoagulants Market Size Growth Rate (2019-2030)
1.5.2 Europe Anticoagulants Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Anticoagulants Market Size Growth Rate (2019-2030)
1.5.4 Latin America Anticoagulants Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Anticoagulants Market Size Growth Rate (2019-2030)
2 Anticoagulants Market by Type
2.1 Type Introduction
2.1.1 Platelet Aggregation Inhibitors (PAI)
2.1.2 Low-Molecular-Weight Heparin (LMWH)
2.1.3 Direct Thrombin Inhibitor (DTI)
2.1.4 Direct Factor Xa Inhibitors (DFXa)
2.1.5 Vitamin K antagonists (VKA)
2.1.6 Others
2.2 Global Anticoagulants Market Size by Type
2.2.1 Global Anticoagulants Market Size Overview by Type (2019-2030)
2.2.2 Global Anticoagulants Historic Market Size Review by Type (2019-2024)
2.2.3 Global Anticoagulants Market Size Forecasted by Type (2025-2030)
2.3 Global Anticoagulants Market Size by Regions
2.3.1 North America Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Anticoagulants Market Size Breakdown by Type (2019-2024)
3 Anticoagulants Market by Application
3.1 Type Introduction
3.1.1 VTE
3.1.2 ACS/MI
3.1.3 AF
3.1.4 Others
3.2 Global Anticoagulants Market Size by Application
3.2.1 Global Anticoagulants Market Size Overview by Application (2019-2030)
3.2.2 Global Anticoagulants Historic Market Size Review by Application (2019-2024)
3.2.3 Global Anticoagulants Market Size Forecasted by Application (2025-2030)
3.3 Global Anticoagulants Market Size by Regions
3.3.1 North America Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Anticoagulants Market Size Breakdown by Application (2019-2024)
4 Global Market Dynamics
4.1 Anticoagulants Industry Trends
4.2 Anticoagulants Industry Drivers
4.3 Anticoagulants Industry Opportunities and Challenges
4.4 Anticoagulants Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Anticoagulants Revenue (2019-2024)
5.2 Global Anticoagulants Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Anticoagulants Key Company Headquarters & Area Served
5.4 Global Anticoagulants Company, Product Type & Application
5.5 Global Anticoagulants Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Anticoagulants Market CR5 and HHI
5.6.2 Global Top 5 and 10 Anticoagulants Players Market Share by Revenue in 2023
5.6.3 2023 Anticoagulants Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Sanofi
6.1.1 Sanofi Comapny Information
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Sanofi Anticoagulants Product Portfolio
6.1.5 Sanofi Recent Developments
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Comapny Information
6.2.2 Bristol-Myers Squibb Business Overview
6.2.3 Bristol-Myers Squibb Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Anticoagulants Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments
6.3 Bayer
6.3.1 Bayer Comapny Information
6.3.2 Bayer Business Overview
6.3.3 Bayer Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Bayer Anticoagulants Product Portfolio
6.3.5 Bayer Recent Developments
6.4 Johnson & Johnson.
6.4.1 Johnson & Johnson. Comapny Information
6.4.2 Johnson & Johnson. Business Overview
6.4.3 Johnson & Johnson. Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson. Anticoagulants Product Portfolio
6.4.5 Johnson & Johnson. Recent Developments
6.5 Genentech (Roche)
6.5.1 Genentech (Roche) Comapny Information
6.5.2 Genentech (Roche) Business Overview
6.5.3 Genentech (Roche) Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Genentech (Roche) Anticoagulants Product Portfolio
6.5.5 Genentech (Roche) Recent Developments
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Comapny Information
6.6.2 Boehringer Ingelheim Business Overview
6.6.3 Boehringer Ingelheim Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Anticoagulants Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments
6.7 Lilly
6.7.1 Lilly Comapny Information
6.7.2 Lilly Business Overview
6.7.3 Lilly Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Lilly Anticoagulants Product Portfolio
6.7.5 Lilly Recent Developments
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Comapny Information
6.8.2 Daiichi Sankyo Business Overview
6.8.3 Daiichi Sankyo Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Anticoagulants Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments
6.9 Otsuka
6.9.1 Otsuka Comapny Information
6.9.2 Otsuka Business Overview
6.9.3 Otsuka Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Otsuka Anticoagulants Product Portfolio
6.9.5 Otsuka Recent Developments
6.10 AstraZeneca
6.10.1 AstraZeneca Comapny Information
6.10.2 AstraZeneca Business Overview
6.10.3 AstraZeneca Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 AstraZeneca Anticoagulants Product Portfolio
6.10.5 AstraZeneca Recent Developments
6.11 Pfizer
6.11.1 Pfizer Comapny Information
6.11.2 Pfizer Business Overview
6.11.3 Pfizer Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Pfizer Anticoagulants Product Portfolio
6.11.5 Pfizer Recent Developments
6.12 Aspen
6.12.1 Aspen Comapny Information
6.12.2 Aspen Business Overview
6.12.3 Aspen Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Aspen Anticoagulants Product Portfolio
6.12.5 Aspen Recent Developments
6.13 The Medicines Company
6.13.1 The Medicines Company Comapny Information
6.13.2 The Medicines Company Business Overview
6.13.3 The Medicines Company Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 The Medicines Company Anticoagulants Product Portfolio
6.13.5 The Medicines Company Recent Developments
7 North America
7.1 North America Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Anticoagulants Market Size by Country (2019-2024)
7.3 North America Anticoagulants Market Size Forecast by Country (2025-2030)
8 Europe
8.1 Europe Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Anticoagulants Market Size by Country (2019-2024)
8.3 Europe Anticoagulants Market Size Forecast by Country (2025-2030)
9 Asia-Pacific
9.1 Asia-Pacific Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Anticoagulants Market Size by Country (2019-2024)
9.3 Asia-Pacific Anticoagulants Market Size Forecast by Country (2025-2030)
10 Latin America
10.1 Latin America Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Anticoagulants Market Size by Country (2019-2024)
10.3 Latin America Anticoagulants Market Size Forecast by Country (2025-2030)
11 Middle East & Africa
11.1 Middle East & Africa Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Anticoagulants Market Size by Country (2019-2024)
11.3 Middle East & Africa Anticoagulants Market Size Forecast by Country (2025-2030)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings